Home › Companies › Collegium Pharmaceutical, Inc. › 2025-2026

Collegium Pharmaceutical, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Collegium Pharmaceutical, Inc.’s Form 8-K, filed 2026-05-15 (Item 5.07 on EDGAR). Page generated 02 October 2026.

18Reported items
335Asset managers
3,584Fund votes
2026-05-14Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Collegium Pharmaceutical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Collegium Pharmaceutical, Inc.

These tallies are Collegium Pharmaceutical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Collegium Pharmaceutical, Inc. — official shareholder meeting results, meeting held 2026-05-14
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Rita Balice-Gordon	25,890,238	1,343,456	186,467	--	1,790,765	Majority: yes
Elect Director: Garen Bohlin	27,093,924	243,649	82,588	--	1,790,765	Majority: yes
Elect Director: Michael Donovan	27,383,194	35,519	1,448	--	1,790,765	Majority: yes
Elect Director: John Freund, M.D.	26,907,371	510,601	2,189	--	1,790,765	Majority: yes
Elect Director: Vikram Karnani	27,243,959	173,863	2,339	--	1,790,765	Majority: yes
Elect Director: Nancy Lurker	27,379,677	39,738	746	--	1,790,765	Majority: yes
Elect Director: Carlos Paya, M.D., Ph.D.	26,695,542	710,809	13,810	--	1,790,765	Majority: yes
Elect Director: Gino Santini	26,824,258	593,714	2,189	--	1,790,765	Majority: yes
Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.	26,313,792	1,100,723	5,646	--	1,790,765	Majority: yes
Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.	28,953,181	252,815	4,930	--	0	Majority: yes

Source: Collegium Pharmaceutical, Inc., Form 8-K, filed with the SEC on 2026-05-15 — read the filing on EDGAR.

How asset managers voted at the Collegium Pharmaceutical, Inc. 2025-2026 meeting

Each item below shows how the 335 asset managers that disclosed a Collegium Pharmaceutical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Collegium Pharmaceutical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval of, on an advisory basis, the compensation of the Company's named executive officers

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 26,313,792AGAINST: 1,100,723

Collegium Pharmaceutical, Inc.’s own tally for this item (“Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.”): 26,313,792 for, 1,100,723 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 81% for, 3% against (85% of the company cast a for/against vote).

The 333 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 96%

FOR: 96.1%AGAINST: 3.9%NOT VOTED: 0.0%

Largest asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	3,677,095	0	For
Janus Henderson	2,610,572	0	For
Vanguard	2,375,789	3	For
Invesco	2,331,912	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	1,494,057	0	For
Capitol Series Trust	1,430,708	0	For
MUTUAL FUND SERIES TRUST	1,408,035	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	1,369,509	0	For
State Street	1,331,006	1,075	For
MFS	1,196,583	0	For
Charles Schwab	932,879	0	For
Rubric Capital Management LP	914,347	0	For
American Century	0	898,496	Against
PRINCIPAL GLOBAL INVESTORS	895,114	0	For
Fidelity	864,221	0	For
GEODE CAPITAL MANAGEMENT, LLC	819,370	0	For
Victory Capital	812,342	0	For
Principal	618,838	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	561,696	0	For
Loomis Sayles	426,409	0	For
Renaissance	400,901	0	For
SEI	343,315	0	For
Dimensional	289,969	0	For
Northern Trust	280,048	0	For
Royce	272,786	0	For

Showing the 25 largest of 333 asset managers. See all 333 in the interactive database.

2. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 28,953,181AGAINST: 252,815

Collegium Pharmaceutical, Inc.’s own tally for this item (“Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”): 28,953,181 for, 252,815 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 89% for, 0.8% against (90% of the company cast a for/against vote).

The 108 asset managers below cast 99.9% of the shares they voted on this item FOR (16,609,415 for, 16,103 against).

FOR 99.9%

FOR: 16,609,415 (99.9%)AGAINST: 16,103 (0.1%)

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,104,863	0	For
Capitol Series Trust	1,430,708	0	For
MUTUAL FUND SERIES TRUST	1,408,035	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,925	66	For
Principal	618,838	0	For
Charles Schwab	437,957	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
Empower	160,054	0	For
THIRD AVENUE TRUST	154,824	0	For
SEI	132,154	0	For
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
UNIFIED SERIES TRUST	79,564	0	For

Showing the 25 largest of 108 asset managers. See all 108 in the interactive database.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 89 asset managers below cast 98% of the shares they voted on this item FOR (13,922,762 for, 280,904 against).

FOR: 13,922,762 (98.0%)AGAINST: 280,904 (2.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,991	0	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	0	136,508	Against
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	0	78,552	Against
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	11,499	63,167	Against
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 89 asset managers below cast 99.8% of the shares they voted on this item FOR (14,188,645 for, 15,021 against).

FOR: 14,188,645 (99.9%)AGAINST: 15,021 (0.1%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,925	66	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	136,508	0	For
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	78,552	0	For
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	74,666	0	For
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Gino Santini

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 89 asset managers below cast 99.8% of the shares they voted on this item FOR (14,185,942 for, 17,724 against).

FOR: 14,185,942 (99.9%)AGAINST: 17,724 (0.1%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,925	66	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	136,508	0	For
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	78,552	0	For
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	74,666	0	For
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.8%

The 89 asset managers below cast 99.8% of the shares they voted on this item FOR (14,188,645 for, 15,021 against).

FOR: 14,188,645 (99.9%)AGAINST: 15,021 (0.1%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,925	66	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	136,508	0	For
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	78,552	0	For
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	74,666	0	For
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Michael Donovan

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 89 asset managers below cast 100% of the shares they voted on this item FOR (14,203,666 for, 0 against).

FOR: 14,203,666 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	2,442,909	For
Vanguard	2,084,906	For
Capitol Series Trust	1,430,708	For
MFS	1,196,583	For
Invesco	1,064,025	For
Fidelity	802,587	For
State Street	647,991	For
Principal	618,838	For
American Century	437,768	For
Royce	267,383	For
Victory Capital	262,402	For
Pacer Funds Trust	256,365	For
RBB FUND, INC.	207,319	For
Dimensional	204,566	For
Bridge Builder Trust	171,800	For
World Funds Trust	165,208	For
Janus Detroit Street Trust	161,118	For
THIRD AVENUE TRUST	154,824	For
Empower	136,508	For
OLD WESTBURY FUNDS INC	97,655	For
MassMutual	81,400	For
Loomis Sayles	78,552	For
AMERICAN BEACON FUNDS	75,880	For
Brighthouse	74,666	For
Equitable	74,289	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Nancy Lurker

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 89 asset managers below cast 100% of the shares they voted on this item FOR (14,203,666 for, 0 against).

FOR: 14,203,666 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Vote
BlackRock	2,442,909	For
Vanguard	2,084,906	For
Capitol Series Trust	1,430,708	For
MFS	1,196,583	For
Invesco	1,064,025	For
Fidelity	802,587	For
State Street	647,991	For
Principal	618,838	For
American Century	437,768	For
Royce	267,383	For
Victory Capital	262,402	For
Pacer Funds Trust	256,365	For
RBB FUND, INC.	207,319	For
Dimensional	204,566	For
Bridge Builder Trust	171,800	For
World Funds Trust	165,208	For
Janus Detroit Street Trust	161,118	For
THIRD AVENUE TRUST	154,824	For
Empower	136,508	For
OLD WESTBURY FUNDS INC	97,655	For
MassMutual	81,400	For
Loomis Sayles	78,552	For
AMERICAN BEACON FUNDS	75,880	For
Brighthouse	74,666	For
Equitable	74,289	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

9. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 89 asset managers below cast 98% of the shares they voted on this item FOR (13,873,856 for, 281,091 against).

FOR: 13,873,856 (97.7%)AGAINST: 281,091 (2.0%)ABSTAIN: 48,719 (0.3%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,991	0	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	0	136,508	Against
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	0	78,552	Against
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	11,499	63,167	Against
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

10. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya, M.D., Ph.D. and Gino Santini as directors to hold office until the 2027 Annual Meeting: Vikram Karnani

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 89 asset managers below cast 99.9% of the shares they voted on this item FOR (14,203,600 for, 66 against).

FOR: 14,203,600 (100.0%)AGAINST: 66 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Michael Donovan, John Freund, M.D., Vikram Karnani, Nancy” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
BlackRock	2,442,909	0	For
Vanguard	2,084,906	0	For
Capitol Series Trust	1,430,708	0	For
MFS	1,196,583	0	For
Invesco	1,064,025	0	For
Fidelity	802,587	0	For
State Street	647,925	66	For
Principal	618,838	0	For
American Century	437,768	0	For
Royce	267,383	0	For
Victory Capital	262,402	0	For
Pacer Funds Trust	256,365	0	For
RBB FUND, INC.	207,319	0	For
Dimensional	204,566	0	For
Bridge Builder Trust	171,800	0	For
World Funds Trust	165,208	0	For
Janus Detroit Street Trust	161,118	0	For
THIRD AVENUE TRUST	154,824	0	For
Empower	136,508	0	For
OLD WESTBURY FUNDS INC	97,655	0	For
MassMutual	81,400	0	For
Loomis Sayles	78,552	0	For
AMERICAN BEACON FUNDS	75,880	0	For
Brighthouse	74,666	0	For
Equitable	74,289	0	For

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.

11. Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 26,695,542AGAINST: 710,809

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Carlos Paya, M.D., Ph.D.”): 26,695,542 for, 710,809 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).

The 24 asset managers below cast 99.9% of the shares they voted on this item FOR (2,521,849 for, 3 against).

FOR 99.9%

FOR: 2,521,849 (100.0%)AGAINST: 3 (0.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Carlos Paya, M.D., Ph.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	For
Charles Schwab	437,957	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	For
SEI	132,154	0	For
UNIFIED SERIES TRUST	79,564	0	For
Prudential/PGIM	60,426	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
SEI Exchange Traded Funds	43,300	0	For
JPMorgan	35,422	0	For
Empower	23,546	0	For
TARGET PORTFOLIO TRUST	20,200	0	For
Vanguard	19,954	3	For
Global X	14,719	0	For
Zacks Trust	11,750	0	For
RBB Fund Trust	6,301	0	For
STERLING CAPITAL FUNDS	5,652	0	For
New York Life	4,254	0	For
NEW COVENANT FUNDS	2,915	0	For
Venerable Variable Insurance Trust	2,390	0	For
NYLIM VP FUNDS TRUST	2,174	0	For
CLEARWATER INVESTMENT TRUST	1,400	0	For
Nationwide	1,363	0	For
Advisors' Inner Circle Fund III	165	0	For
SARATOGA ADVANTAGE TRUST	8	0	For

12. Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 27,093,924AGAINST: 243,649

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Garen Bohlin”): 27,093,924 for, 243,649 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 84% for, 0.8% against (84% of the company cast a for/against vote).

The 24 asset managers below cast 99.9% of the shares they voted on this item FOR (2,521,685 for, 166 against).

FOR 99.9%

FOR: 2,521,685 (100.0%)AGAINST: 166 (0.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Garen Bohlin” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	For
Charles Schwab	437,957	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	For
SEI	132,154	0	For
UNIFIED SERIES TRUST	79,564	0	For
Prudential/PGIM	60,426	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
SEI Exchange Traded Funds	43,300	0	For
JPMorgan	35,422	0	For
Empower	23,546	0	For
TARGET PORTFOLIO TRUST	20,200	0	For
Vanguard	19,955	1	For
Global X	14,719	0	For
Zacks Trust	11,750	0	For
RBB Fund Trust	6,301	0	For
STERLING CAPITAL FUNDS	5,652	0	For
New York Life	4,254	0	For
NEW COVENANT FUNDS	2,915	0	For
Venerable Variable Insurance Trust	2,390	0	For
NYLIM VP FUNDS TRUST	2,174	0	For
CLEARWATER INVESTMENT TRUST	1,400	0	For
Nationwide	1,363	0	For
Advisors' Inner Circle Fund III	0	165	Against
SARATOGA ADVANTAGE TRUST	8	0	For

13. Election of directors to hold office until the 2027 Annual Meeting: Gino Santini

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 26,824,258AGAINST: 593,714

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Gino Santini”): 26,824,258 for, 593,714 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).

The 24 asset managers below cast 99.7% of the shares they voted on this item FOR (2,515,257 for, 6,595 against).

FOR 99.7%

FOR: 2,515,257 (99.7%)AGAINST: 6,595 (0.3%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Gino Santini” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	For
Charles Schwab	437,957	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	For
SEI	132,154	0	For
UNIFIED SERIES TRUST	79,564	0	For
Prudential/PGIM	60,426	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
SEI Exchange Traded Funds	43,300	0	For
JPMorgan	35,422	0	For
Empower	23,546	0	For
TARGET PORTFOLIO TRUST	20,200	0	For
Vanguard	19,955	2	For
Global X	14,719	0	For
Zacks Trust	11,750	0	For
RBB Fund Trust	6,301	0	For
STERLING CAPITAL FUNDS	5,652	0	For
New York Life	0	4,254	Against
NEW COVENANT FUNDS	2,915	0	For
Venerable Variable Insurance Trust	2,390	0	For
NYLIM VP FUNDS TRUST	0	2,174	Against
CLEARWATER INVESTMENT TRUST	1,400	0	For
Nationwide	1,363	0	For
Advisors' Inner Circle Fund III	0	165	Against
SARATOGA ADVANTAGE TRUST	8	0	For

14. Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 26,907,371AGAINST: 510,601

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Freund, M.D.”): 26,907,371 for, 510,601 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).

The 24 asset managers below cast 99.9% of the shares they voted on this item FOR (2,521,685 for, 167 against).

FOR 99.9%

FOR: 2,521,685 (100.0%)AGAINST: 167 (0.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: John Freund, M.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	For
Charles Schwab	437,957	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	For
SEI	132,154	0	For
UNIFIED SERIES TRUST	79,564	0	For
Prudential/PGIM	60,426	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
SEI Exchange Traded Funds	43,300	0	For
JPMorgan	35,422	0	For
Empower	23,546	0	For
TARGET PORTFOLIO TRUST	20,200	0	For
Vanguard	19,955	2	For
Global X	14,719	0	For
Zacks Trust	11,750	0	For
RBB Fund Trust	6,301	0	For
STERLING CAPITAL FUNDS	5,652	0	For
New York Life	4,254	0	For
NEW COVENANT FUNDS	2,915	0	For
Venerable Variable Insurance Trust	2,390	0	For
NYLIM VP FUNDS TRUST	2,174	0	For
CLEARWATER INVESTMENT TRUST	1,400	0	For
Nationwide	1,363	0	For
Advisors' Inner Circle Fund III	0	165	Against
SARATOGA ADVANTAGE TRUST	8	0	For

15. Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 27,383,194AGAINST: 35,519

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Michael Donovan”): 27,383,194 for, 35,519 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 84% for, 0.2% against (85% of the company cast a for/against vote).

The 24 asset managers below cast 100% of the shares they voted on this item FOR (2,521,852 for, 0 against).

FOR 100%

FOR: 2,521,852 (100.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Michael Donovan” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	1,408,035	For
Charles Schwab	437,957	For
HUSSMAN INVESTMENT TRUST	160,000	For
SEI	132,154	For
UNIFIED SERIES TRUST	79,564	For
Prudential/PGIM	60,426	For
ADVISORS' INNER CIRCLE FUND	48,200	For
SEI Exchange Traded Funds	43,300	For
JPMorgan	35,422	For
Empower	23,546	For
TARGET PORTFOLIO TRUST	20,200	For
Vanguard	19,957	For
Global X	14,719	For
Zacks Trust	11,750	For
RBB Fund Trust	6,301	For
STERLING CAPITAL FUNDS	5,652	For
New York Life	4,254	For
NEW COVENANT FUNDS	2,915	For
Venerable Variable Insurance Trust	2,390	For
NYLIM VP FUNDS TRUST	2,174	For
CLEARWATER INVESTMENT TRUST	1,400	For
Nationwide	1,363	For
Advisors' Inner Circle Fund III	165	For
SARATOGA ADVANTAGE TRUST	8	For

16. Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 27,379,677AGAINST: 39,738

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Nancy Lurker”): 27,379,677 for, 39,738 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 84% for, 0.2% against (85% of the company cast a for/against vote).

The 24 asset managers below cast 100% of the shares they voted on this item FOR (1,177,476 for, 0 against).

FOR 100%

FOR: 1,177,476 (100.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Nancy Lurker” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Vote
Charles Schwab	437,957	For
HUSSMAN INVESTMENT TRUST	160,000	For
SEI	132,154	For
UNIFIED SERIES TRUST	79,564	For
MUTUAL FUND SERIES TRUST	63,659	For
Prudential/PGIM	60,426	For
ADVISORS' INNER CIRCLE FUND	48,200	For
SEI Exchange Traded Funds	43,300	For
JPMorgan	35,422	For
Empower	23,546	For
TARGET PORTFOLIO TRUST	20,200	For
Vanguard	19,957	For
Global X	14,719	For
Zacks Trust	11,750	For
RBB Fund Trust	6,301	For
STERLING CAPITAL FUNDS	5,652	For
New York Life	4,254	For
NEW COVENANT FUNDS	2,915	For
Venerable Variable Insurance Trust	2,390	For
NYLIM VP FUNDS TRUST	2,174	For
CLEARWATER INVESTMENT TRUST	1,400	For
Nationwide	1,363	For
Advisors' Inner Circle Fund III	165	For
SARATOGA ADVANTAGE TRUST	8	For

17. Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 25,890,238AGAINST: 1,343,456

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 25,890,238 for, 1,343,456 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 80% for, 4% against (84% of the company cast a for/against vote).

The 24 asset managers below cast 90% of the shares they voted on this item FOR (2,267,821 for, 254,030 against).

FOR 90%10%

FOR: 2,267,821 (89.9%)AGAINST: 254,030 (10.1%)ABSTAIN: 1 (0.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Rita Balice-Gordon, Ph.D.” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	0	For
Charles Schwab	437,957	0	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	0	For
SEI	0	132,154	0	Against
UNIFIED SERIES TRUST	79,564	0	0	For
Prudential/PGIM	60,426	0	0	For
ADVISORS' INNER CIRCLE FUND	0	48,200	0	Against
SEI Exchange Traded Funds	0	43,300	0	Against
JPMorgan	35,422	0	0	For
Empower	23,546	0	0	For
TARGET PORTFOLIO TRUST	20,200	0	0	For
Vanguard	15,256	4,700	1	For
Global X	0	14,719	0	Against
Zacks Trust	11,750	0	0	For
RBB Fund Trust	6,301	0	0	For
STERLING CAPITAL FUNDS	0	5,652	0	Against
New York Life	4,254	0	0	For
NEW COVENANT FUNDS	0	2,915	0	Against
Venerable Variable Insurance Trust	0	2,390	0	Against
NYLIM VP FUNDS TRUST	2,174	0	0	For
CLEARWATER INVESTMENT TRUST	1,400	0	0	For
Nationwide	1,363	0	0	For
Advisors' Inner Circle Fund III	165	0	0	For
SARATOGA ADVANTAGE TRUST	8	0	0	For

18. Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 27,243,959AGAINST: 173,863

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Vikram Karnani”): 27,243,959 for, 173,863 against, per its Form 8-K filed 2026-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,433,779 outstanding shares: 84% for, 0.6% against (85% of the company cast a for/against vote).

The 24 asset managers below cast 99.9% of the shares they voted on this item FOR (2,521,851 for, 1 against).

FOR 99.9%

FOR: 2,521,851 (100.0%)AGAINST: 1 (0.0%)

Largest asset managers voting on “Election of directors to hold office until the 2027 Annual Meeting: Vikram Karnani” at Collegium Pharmaceutical, Inc., 2025-2026
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	1,408,035	0	For
Charles Schwab	437,957	0	For
HUSSMAN INVESTMENT TRUST	160,000	0	For
SEI	132,154	0	For
UNIFIED SERIES TRUST	79,564	0	For
Prudential/PGIM	60,426	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
SEI Exchange Traded Funds	43,300	0	For
JPMorgan	35,422	0	For
Empower	23,546	0	For
TARGET PORTFOLIO TRUST	20,200	0	For
Vanguard	19,956	1	For
Global X	14,719	0	For
Zacks Trust	11,750	0	For
RBB Fund Trust	6,301	0	For
STERLING CAPITAL FUNDS	5,652	0	For
New York Life	4,254	0	For
NEW COVENANT FUNDS	2,915	0	For
Venerable Variable Insurance Trust	2,390	0	For
NYLIM VP FUNDS TRUST	2,174	0	For
CLEARWATER INVESTMENT TRUST	1,400	0	For
Nationwide	1,363	0	For
Advisors' Inner Circle Fund III	165	0	For
SARATOGA ADVANTAGE TRUST	8	0	For

Largest Collegium Pharmaceutical, Inc. shareholders voting in 2025-2026

Ranked by the number of Collegium Pharmaceutical, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 32,433,779 shares outstanding at the time of that meeting.

Top Collegium Pharmaceutical, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	BlackRock	11.34%
2	Janus Henderson	8.05%
3	Vanguard	7.33%
4	Invesco	7.19%
5	FULLER & THALER ASSET MANAGEMENT, INC.	4.61%
6	Capitol Series Trust	4.41%
7	MUTUAL FUND SERIES TRUST	4.34%
8	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	4.22%
9	State Street	4.11%
10	MFS	3.69%

Reported Collegium Pharmaceutical, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Collegium Pharmaceutical, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.83%	13F
Vanguard Group	6.96%	13F
JANUS HENDERSON GROUP PLC	5.63%	13G
Integrated Core Strategies (US) LLC	5.45%	13G
Fuller & Thaler Asset Management, Inc.	5.03%	13G
PRINCIPAL GLOBAL INVESTORS	5.03%	13G
Invesco	4.91%	13F
Renaissance Technologies	4.53%	13F
State Street	4.39%	13F
Eventide Asset Management, LLC	4.39%	13G

Percentages above are of 32,433,779 shares outstanding, as reported by Collegium Pharmaceutical, Inc. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Collegium Pharmaceutical, Inc.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Collegium Pharmaceutical, Inc.'s shareholder meeting held 2026-05-14, in the 2025-2026 proxy season, 335 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,584 separate fund positions. Their filings are grouped here into 18 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Collegium Pharmaceutical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-15.

Collegium Pharmaceutical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).